Research Site

Rotorua 3040

2 studies enrolling now · 5 studies all time

What they study most

Acute Coronary Syndrome, Advanced Clear Cell Renal Cell Carcinoma, Asthma, Cardiovascular Disease, Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD), Metastatic Clear Cell Renal Cell Carcinoma

Studies at this site

• Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma — Recruiting now
• A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event — Recruiting now
• Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS) — Completed
• Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS — Completed
• Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia — Completed